Warby Parker Inc. (WRBY) is a leading name in the eyewear field, with designer-looking prescription glasses at reasonable prices. Yet it has just a tiny morsel of the overall market ($66 billion in ...
Learn more› By Kaitlyn Wells and Zoe Vanderweide If you believe the hype, blue-light blocking glasses will prevent headaches, decrease eyestrain, and help you sleep like a baby. But do they work?
It's estimated that 8% of the American population suffers from visual impairments, with related healthcare costs totaling over $40 billion annually. Fortunately, a new telehealth collaboration between ...
Loop Capital raised the firm’s price target on Warby Parker (WRBY) to $27 from $19 and keeps a Hold rating on the shares. The firm’s proprietary eye exam availability tracker for Warby Parker ...